Optimal use of asparaginase for acute lymphoblastic leukaemia
Dr Ibrahim Aldoss - City of Hope, Duarte, USA
Optimal use of asparaginase for acute lymphoblastic leukaemia ( Dr Ibrahim Aldoss -  City of Hope, Duarte, USA )
10 Nov 2021
Mobile supportive care for children and young adults with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
Mobile supportive care for children and young adults with ALL ( Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria )
10 Nov 2021
Post-HSCT management of paediatric patients with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
Post-HSCT management of paediatric patients with ALL ( Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria )
10 Nov 2021
Immunotherapy of T-ALL: Opportunities and hurdles
Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA
Immunotherapy of T-ALL: Opportunities and hurdles ( Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA )
10 Nov 2021
Workshop diagnostics procedures in ALL
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Workshop diagnostics procedures in ALL ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
10 Nov 2021
Practical applications on new data of genetic ALL subtypes
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Practical applications on new data of genetic ALL subtypes ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
10 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng  - National University Cancer Institute, Singapore )
29 Oct 2021
High-risk SMM imaging and NDMM treatment
Dr Elena Zamagni - University of Bologna, Bologna, Italy
High-risk SMM imaging and NDMM treatment ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
28 Oct 2021
Rescue after daratumumab failure
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
26 Oct 2021